Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 7Observational 2

Sponsor

Cancer Type

Endocrine 1Breast 1

Conditions

Breast Neoplasms 2934Neoplasms 2633Lung Neoplasms 1370Colorectal Neoplasms 1332Prostatic Neoplasms 1216Carcinoma, Non-Small-Cell Lung 1080Carcinoma, Hepatocellular 783Stomach Neoplasms 721Pancreatic Neoplasms 704Ovarian Neoplasms 586Colonic Neoplasms 534Uterine Cervical Neoplasms 497Head and Neck Neoplasms 496Rectal Neoplasms 472Melanoma 467Multiple Myeloma 463Esophageal Neoplasms 422Neoplasm Metastasis 418Brain Neoplasms 405Lymphoma 399Precursor Cell Lymphoblastic Leukemia-Lymphoma 398Urinary Bladder Neoplasms 387Leukemia, Myeloid, Acute 387Leukemia 339Carcinoma, Renal Cell 329Liver Neoplasms 320Endometrial Neoplasms 319Hematologic Neoplasms 313Recurrence 298Disease 275

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Diabetes Insipidus × Clear all
NCT01465672 2014-05-20

Copeptin as a Diagnostic Marker in the Management of Neurosurgical Patients With Disturbance of Water Homeostasis

University Hospital, Basel, Switzerland

Completed
125 enrolled
Endocrine

Diabetes Insipidus, Inappropriate ADH Syndrome, Pituitary Neoplasms

NCT00390962 2008-09-23

The "COSMOS"-Study (Copeptin in Osmoregulation and Stress Assessment)

University Hospital, Basel, Switzerland

Completed
469 enrolled
Breast

Hemorrhagic Stroke, Carcinoma, Intraductal, Noninfiltrating, Ischemic Attack, Transient, Diabetes Insipidus, Inappropriate ADH Syndrome, Stroke

Data powered by HemOnc (CC BY 4.0) Colophon âš¡